엔비피헬스케어

NBP Healthcare is a South Korean biotechnology company specializing in the development of microbiome-based therapeutics and high-functional health foods. The company utilizes its proprietary K-Microbiome platform to discover and validate specific microbial strains and natural extracts for various chronic conditions. Their clinical pipeline is led by NBP1501, a live biotherapeutic candidate for non-alcoholic fatty liver disease (NAFLD), and NBP1601 for atopic dermatitis. By integrating microbial science with clinical research, NBP Healthcare aims to provide innovative solutions for liver health, immune modulation, and cognitive function. The company maintains a strong strategic partnership with Novarex for the commercialization and manufacturing of its functional products.